posted on 2015-12-04, 00:00authored byEgoitz Conde, Iván Rivilla, Amaia Larumbe, Fernando P. Cossío
Both
(5R)- and (5S)-1,7-diazaspiro[4.4]nonan-6-ones
are obtained via a sequence of interrupted and completed stepwise
(3 + 2) cycloadditions between azomethine ylides and π-deficient
alkenes. The only source of chirality along the whole process is an
enantiopure ferrocenyl pyrrolidine catalytic ligand. When the starting
imine incorporates two aryl groups or one aryl group with one electron-releasing
substituent, the reaction between the azomethine ylide and the alkene
stops at the first step, leading to the corresponding Michael adduct.
When imines derived from p-methoxybenzaldehyde are
used, the corresponding syn-α-amino-γ-nitro
ester is obtained with almost complete enantiocontrol. In contrast,
imines derived from benzophenone lead to the corresponding anti analogue. From this interrupted (3 + 2) cycloaddition, cis- and trans-α-amino-γ-lactams
can be obtained via hydrogenation of the nitro group followed by in
situ cyclization. Imines derived from these latter compounds are the
precursors of N-metalated azomethine ylides from
which up to four new chiral centers can be generated via completed
(3 + 2) cycloaddition reactions with full regio- and diastereocontrol. Cis- and trans-γ-lactams lead to
opposite bis-spiropyrrolidine enantiomers. Therefore, both enantiomeric
series of spiro compounds can be obtained by means of the same catalytic
system. The potential of these rigid, densely substituted homochiral
compounds in medicinal chemistry is briefly described.